Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking

With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

Phase Separator is a unique new pipetting capability of the new Air Flexible Channel Arm™ (Air FCA) on Tecan’s flagship liquid handling platform, the Fluent® Automation Workstation. It addresses the critical challenge of detecting liquid–liquid interfaces and effectively separating neighboring phases, while avoiding the risk of contamination makes it ideal for separating plasma in centrifuged blood samples.

Tecan’s innovative technology detects liquid levels with pinpoint precision inside the tube, so there is no interference from barcodes or other tube markings. By combining phase detection with the pipetting action, Phase Separator can achieve remarkable speeds, working with either tubes or plates. Processing speed is further enhanced when all eight channels on the Air FCA are used in parallel, enabling the aspiration of plasma from 24 tubes of centrifuged blood in under 10 minutes,* and is twice as fast on dual-arm systems. These benefits come with no loss of bench space and no additional equipment to maintain.

"Phase Separator represents a significant advance in liquid-separation technology,” said Luca Valeggia, Senior Vice President of Laboratory Automation at Tecan. “With its precision and streamlined workflow, it will deliver new levels of efficiency and reliability for both research and clinical applications. It will make an enormous contribution to liquid biopsy workflows, impacting disease diagnosis and monitoring, and to broader research applications, where it will help to accelerate discovery."

The launch of Phase Separator further demonstrates Tecan's commitment to scaling healthcare innovation globally. With this patent-pending innovation, biological samples can be processed faster, more accurately and even more efficiently than with previous methods. These improvements translate to productivity gains and cost savings for laboratories, with a particular impact on the rapidly evolving field of liquid biopsy.

For further information about Tecan's Phase Separator technology, please visit our dedicated landing page at www.tecan.com/phase-separator.

*Timing is volume dependent. Time given for separation volumes of 5 ml.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2024, February 13). Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking. News-Medical. Retrieved on July 19, 2024 from https://www.news-medical.net/news/20230721/Tecans-Phase-Separatore284a2-advancing-automation-for-liquid-biopsy-and-biobanking.aspx.

  • MLA

    Tecan. "Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking". News-Medical. 19 July 2024. <https://www.news-medical.net/news/20230721/Tecans-Phase-Separatore284a2-advancing-automation-for-liquid-biopsy-and-biobanking.aspx>.

  • Chicago

    Tecan. "Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking". News-Medical. https://www.news-medical.net/news/20230721/Tecans-Phase-Separatore284a2-advancing-automation-for-liquid-biopsy-and-biobanking.aspx. (accessed July 19, 2024).

  • Harvard

    Tecan. 2024. Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking. News-Medical, viewed 19 July 2024, https://www.news-medical.net/news/20230721/Tecans-Phase-Separatore284a2-advancing-automation-for-liquid-biopsy-and-biobanking.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tecan collaborates with Element Biosciences to provide benchtop NGS